Lumana Invest is a Netherlands-based investment firm specializing in the medical technology and biotech sectors. The firm has been the lead investor in several funding rounds for companies such as Neuroplast, Atro Medical, and Sencure. In 2025, Lumana Invest's portfolio became part of the 819 Evergreen Fund.
Is Lumana Invest the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Lumana Invest, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€500,000 - €10,000,000
Lumana Invest's integration into the 819 Evergreen Fund reflects a commitment to long-term, patient capital in deep tech sectors. Founders should highlight how their innovations address significant societal challenges and align with the fund's focus on sustainable value creation without the constraints of a fixed investment horizon. Emphasizing a strategic vision that benefits from extended partnership periods will resonate with their investment philosophy.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.